1) Alving K, Janson C, Nordvall L. Performance of a new hand-held device for exhaled nitric oxide measurement in adults and children. Respir Res. 2006; 7: 67
|
|
|
2) Anonymous. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005; 171: 912-30
|
|
|
3) Saito J, Sato S, Hasunuma H, et al. Off-line fractional exhaled nitric oxide measurement is useful to screen allergic airway inflammation in an adult population. J Asthma. 2007; 44: 805-10
|
|
|
4) 斎藤純平, 棟方 充. 呼気一酸化窒素(FeNO)の有用性と臨床応用への問題点. 喘息. 2006; 19: 34-40
|
|
|
5) Horvath I, Donnelly LE, Kiss A, et al. Exhaled nitric oxide and hydrogen peroxide concentra-tions in asthmatic smokers. Respiration. 2004; 71: 463-8
|
|
|
6) Saito J, Inoue K, Sugawara A, et al. Exhaled nitric oxide as a marker of airway inflammation for an epidemiologic study in schoolchildren. J Allergy Clin Immunol. 2004; 114: 512-6
|
|
|
7) Kharitonov SA, Yates D, Robbins RA, et al. Increased nitric oxide in exhaled air of asthmatic patients. Lancet. 1994; 343: 133-5
|
|
|
8) Kharitonov SA, Barnes PJ. Exhaled Markers of pulmonary disease. Am J Respir Crit Care Med. 2001; 163: 1693-722
|
|
|
9) Sato S, Saito J, Sato Y, et al. Clinical usefulness of fractional exhaled nitric oxide for diagnosing prolonged cough. Respir Med. 2008; 102: 1452-9
|
|
|
10) Jatakanon A, Lim S, Kharitonov SA, et al. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax. 1998; 53: 91-5
|
|
|
11) Piacentini GL, Bodini A, Costella S, et al. Exhaled nitric oxide, serum ECP and airway responsive-ness in mild asthmatic children. Eur Respir J. 2000; 15: 839-43
|
|
|
12) Strunk RC, Szefler SJ, Phillips BR, et al. Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children. J Allergy Clin Immunol. 2003; 112: 883-92
|
|
|
13) Smith AD, Cowan JO, Filsell S, et al. Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests. Am J Respir Crit Care Med. 2004; 169: 473-8
|
|
|
14) Chatkin JM, Ansarin K, Silkoff PE, et al. Exhaled nitric oxide as a noninvasive assessment of chronic cough. Am J Respir Crit Care Med. 1999; 159: 1810-3
|
|
|
15) Buchvald F, Barladi E, Carraro S, et al. Measurements of exhaled nitric oxide in healthy subjects age 4 to 17 years. J Allergy Clin Immunol. 2005; 115: 1130-6
|
|
|
16) Kovesi T, Kulka R, Dales R. Exhaled nitric oxide concentration is affected by age, height, and race in healthy 9- to 12-year-old children. Chest. 2008; 133: 169-75
|
|
|
17) Olin AC, Rosengren A, Thelle DS, et al. Height, age, and atopy are associated with fraction of exhaled nitric oxide in a large adult general population sample. Chest. 2006; 130: 1319-25
|
|
|
18) Vints AM, Oostveen E, Eeckhaut G, et al. Time-dependent effect of nitrate-rich meals on exhaled nitric oxide in healthy subjects. Chest. 2005; 128: 2465-70
|
|
|
19) Menzies D, Nair A, Lipworth BJ. Portable exhaled nitric oxide measurement: Comparison with the“gold standard"technique. Chest. 2007; 131: 410-4
|
|
|
20) Saito J, Inoue K, Sugawara A, et al. Exhaled nitric oxide as a noninvasive assessment of recurrent wheezers in school children [abstract]. Eur Respir J. 2003; 22: 569s
|
|
|
21) Sato S, Saito J, Hasunuma H, et al. Exhaled nitric oxide as a noninvasive assessment of recurrent wheezers in adults [abstract]. Eur Respir J. 2005; 26: 279s
|
|
|
22) Malmberg LP, Pelkonen AS, Haahtela T, et al. Exhaled nitric oxide rather than lung function distinguishes preschool children with probable asthma. Thorax. 2003; 58: 494-9
|
|
|
23) Warke TJ, Fitch PS, Brown V, et al. Exhaled nitric oxide correlates with airway eosinophils in childhood asthma. Thorax. 2002; 57: 383-7
|
|
|
24) Smith AD, Taylor DR. Is exhaled nitric oxide measurement a useful clinical test in asthma? Curr Opin Allergy Clin Immunol. 2005; 5: 49-56
|
|
|
25) Heffler E, Guida G, Marsico P, et al. Exhaled nitric oxide as a diagnostic test for asthma in rhinitic patients with asthmatic symptoms. Respir Med. 2006; 100: 1981-7
|
|
|
26) Deykin A, Massaro AF, Drazen JM, et al. Exhaled nitric oxide as a diagnostic test for asthma. Am J Respir Crit Care Med. 2002; 165: 1597-601
|
|
|
27) Taylor DR, Pijnenburg MW, Smith AD, et al. Exhaled nitric oxide measurements: clinical application and interpretation. Thorax. 2006; 61: 817-27
|
|
|
28) Kharitonov SA, Yates DH, Barnes PJ. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Res Crit Care Med. 1996; 153: 454-7
|
|
|
29) Jones SL, Herbison P, Cowan JO, et al. Exhaled NO and assessment of anti-inflammatory effects of inhaled steroid: dose-response relationship. Eur Respir J. 2002; 20: 601-8
|
|
|
30) Smith AD, Cowan JO, Brassett KP, et al. Exhaled nitric oxide: a predictor of steroid response. Am J Respir Crit Care Med. 2005; 172: 453-9
|
|
|
31) Smith AD, Cowan JO, Brassett KP, et al. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med. 2005; 352: 2163-73
|
|
|
32) Shaw DE, Berry MA, Thomas M, et al. The use of exhaled nitric oxixde to guide asthma manage-ment. A randomized controlled trial. Am J Respir Crit Care Med. 2007; 176: 231-7
|
|
|
33) Pijnenburg MW, Bakker EM, Hop WC, et al. Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial. Am J Respir Crit Care Med. 2005; 172: 831-6
|
|
|
34) Sandrini A, Ferreira IM, Gutierrez C, et al. Effect of montelukast on exhaled nitric oxide and nonvolatile markers of inflammation in mild asthma. Chest. 2003; 124: 1334-40
|
|
|
35) Ghiro L, Zanconato S, Rampon O, et al. Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children. Eur Respir J. 2002; 20: 630-4
|
|
|
36) Currie GP, Lee DK, Haggart K, et al. Effects of montelukast on surrogate inflammatory markers in corticosteroid-treated patients with asthma. Am J Respir Crit Care Med. 2003; 167: 1232-8
|
|
|
37) Lim S, Tomita K, Carramori G, et al. Low-dose theophylline reduces eosinophilic inflammation but not exhaled nitric oxide in mild asthma. Am J Respir Crit Care Med. 2001; 164: 273-6
|
|
|
38) Haahtela T, Tamminen K, Malmberg LP, et al. Formoterol as needed with or without budesonide in patients with intermittent asthma and raised NO levels in exhaled air: A SOMA study. Eur Respir J. 2006; 28: 748-55
|
|
|
39) Senna G, Passalacqua G, Schiappoli M, et al. Correlation among FEV1, nitric oxide and asthma control test in newly diagnosed asthma. Allergy. 2007; 62: 207-8
|
|
|
40) Zeiger RS, Szefler SJ, Phillips BR, et al. Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma. J Allergy Clin Immunol. 2006; 117: 45-52
|
|
|
41) Jones SL, Kittelson J, Cowan JO, et al. The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am J Respir Crit Care Med. 2001; 164: 738-43
|
|
|
42) Harkins MS, Fiato KL, Iwamoto GK. Exhaled nitric oxide predicts asthma exacerbation. J Asthma. 2004; 41: 471-6
|
|
|
43) Delgado-Corcoran C, Kissoon N, Murphy SP, et al. Exhaled nitric oxide reflects asthma severity and asthma control. Pediatr Crit Care Med. 2004; 5: 48-52
|
|
|
44) Roberts G, Mylonopoulou M, Hurley C, et al. Impairment in quality of life is directly related to the level of allergen exposure and allergic airway inflammation. Clin Exp Allergy. 2005; 35: 1295-300
|
|
|
45) Gronke L, Mucke M, Paasch K, et al. Exhaled NO as a descriptor of the quality of life status in a longitudinal analysis of patients with severe asthma [abstract]. Am J Respir Crit Care Med. 2002; 165: A321
|
|
|
46) Ehrs PO, Sundblad BM, Larsson K. Quality of life and inflammatory markers in mild asthma. Chest. 2006; 129: 624-31
|
|
|